Navigation Links
Vein Therapy News Magazine Publishes Laser Facelift Article by Dr. Robin Fleck
Date:6/24/2013

Prescott, AZ (PRWEB) June 25, 2013

Dermatologist Robin Fleck, M.D., founder and medical director of Southwest Skin and Cancer Institute, is a featured author in this month’s Vein Therapy News Magazine in which she details a cosmetic laser combination that has proved superior to surgical facelift. Dr. Fleck developed the so-called laser facelift in 2012, by combining AccuLift laser liposuction of the neck and jowls, and the Active FX CO2 fractional resurfacing laser. “Each laser stimulates dermal collagen production at a different level of the skin, so it made sense to couple these lasers to increase skin tightening,” explains Dr. Fleck.

According to the article, the Acculift laser lipo procedure is performed first with removal of fat deposits under the chin and jowls while stimulating collagen in these areas. The procedure is painless and performed with only local anesthesia. Downtime involves just 2-3 days of mild bruising and swelling with patients able to return to work after 2 days. No scars are produced as the laser is introduced through a small needle puncture site.

The next step of this process, which is described in the article, is treatment with the Active FX CO2 fractional resurfacing laser. This second procedure can be performed three to six weeks after the laser lipo procedure and has the advantages of removing age spots and fine lines and wrinkles around crow’s feet and upper lip, as well as tightening skin laxity of the eyes and neck. This laser also improves skin tone and texture and dark circles under the eyes. The Active FX laser requires only topical anesthesia and a ten minute session followed by one week of painless social downtime. No scarring or depigmentation results from the use of this laser.

In contrast, surgical face lift and blepharoplasty under general anesthesia have a lengthy downtime with significant morbidity, and produce surgical scars. Rather than promote the body’s ability to naturally produce collagen, the facelift procedure merely repositions the skin, leaving the same dull appearance, dark circles, age spots and wrinkles above the lip and crow’s feet. Because the facelift is more invasive, patients have an increased risk of bleeding and infection, as well as other risks including nerve damage to the facial muscles and changes in skin sensation. Other consequences can include unevenness of the face, the collection of fluid, irregular skin contour, and an enlarged surgical scar.

The laser facelift’s twofold collagen stimulation produces results nearly equivalent to a surgical facelift within 3-4 months as the skin tightening occurs. Advantages include no scarring, minimal downtime, improvement in the condition, tone and texture of the skin, avoidance of general anesthesia, and a price tag which is approximately one-third the cost of a surgical procedure. The laser facelift can be incorporated with Botox, platelet rich plasma injections, and dermal fillers for maximal cosmetic restoration.

Although this procedure has proven to be successful in her hands, in the article, Dr. Fleck warns that candidates should always be screened with a thorough examination. Patients should take into account social behaviors, like smoking, reversing the benefits of the FX laser. These patients would not be ideal candidates for the procedure. Furthermore, patients who take aspirin or over the counter supplements like fish oil or vitamin E should discontinue these products for two weeks prior to the procedure to avoid excessive bleeding after each procedure.

Cosmetic dermatologist, Robin Fleck, M.D., is a double board certified dermatologist and internist, recognized by the American Board of Dermatology and the American Board of Internal Medicine. She is founder and Medical Director of Southwest Skin and Cancer Institute and Body Oasis Laser Aesthetics http://www.rejuvadoc.com. Dr. Fleck is a fellow of the American Society of Laser Medicine and Surgery and the American Academy of Dermatology. Dr. Fleck is also the director of Vein Specialties in Prescott, Arizona and is a member of the American Venous Forum.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10762530.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Rural women less likely to get radiation therapy after lumpectomy for breast cancer
2. New understanding of why anti-cancer therapy stops working at a specific stage
3. Past Life Regression Therapy: Valid Treatment or Ridiculous Foo Foo; Researcher and Author Dr. Heather Friedman Rivera on Dr. Carol Francis Radio Talk Show
4. Genetics of cervical cancer raise concern about antiviral therapy in some cases
5. PREFERRED Therapy Providers, Inc. and WellCare of Arizona Finalize Their Agreement to Offer Medicare Advantage Plan to PREFERRED's Arizona Provider Network
6. June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy
7. Filtersfast.com Launches Spazazz Aromatherapy Spa & Bath Crystals
8. Newly Released Continuing Education Courses Provide Physical and Occupational Therapy Professionals With Opportunities To Expand Skill Sets
9. Preventing eggs death from chemotherapy
10. North American Seminars Receives NY State Approval for a New Physical Therapy Online Continuing Education Course, Examination and Treatment of the SI Joint
11. Plastic Surgery – Is Gene Therapy the Future?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... December 03, 2016 , ... ... to funding innovative lymphoma research and serving the lymphoma community through a comprehensive ... Swirl: A Wine Tasting Event in New York City, with long-time partners The ...
(Date:12/4/2016)... ... ... While James Earl Jones is known for myriad roles on stage and ... Page". One of the forthcoming episodes examines mammogram techniques; a very important part of ... due to early detection. Like any other disease, treatments have a much higher chance ...
(Date:12/4/2016)... , ... December 03, 2016 , ... ... growing Entrepreneurial Company in the Dallas area” Tuesday evening at the 26th Annual ... Hotel, presented by SMU's Cox School’s Caruth Institute for Entrepreneurship. Dallas 100™, co-founded ...
(Date:12/4/2016)... Newport Beach, CA (PRWEB) , ... December 04, ... ... youthful appearance without undergoing major cosmetic surgery can now take advantage of a ... is an advanced skin rejuvenation treatment that reduces the appearance of age spots, ...
(Date:12/4/2016)... ... December 04, 2016 , ... Responsible dental care hinges ... brush properly to achieve optimal results. This important necessity inspired an inventor from Las ... a way to ensure that people break or avoid bad techniques of brushing the ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... Blueprint Medicines Corporation (NASDAQ: BPMC ... kinase medicines for patients with genomically defined diseases, ... trial evaluating BLU-285, an investigational medicine for the ... Blueprint Medicines is developing BLU-285 as a potent, ... 90 to 95 percent of patients with SM ...
(Date:12/4/2016)... HANOVER, N.J. , Dec. 3, 2016  Results ... (crizanlizumab, formerly SelG1), an anti-P-selectin antibody, reduced the median ... 45.3% compared to placebo (1.63 vs 2.98, p=0.010) in ... today announced that the data are being featured in ... American Society of Hematology (ASH) Annual Meeting and presented ...
(Date:12/2/2016)... - bioLytical lanza el INSTI HIV Self Test para el mercado africano ... Continue Reading ... New: INSTI Self Test! (PRNewsFoto/bioLytical ... bioLytical Laboratories (la "Compañía"), un líder mundial en ... de su INSTI HIV Self Test  a África con una versión de menor ...
Breaking Medicine Technology: